Cabestelle Biopharma
Company
|
France, L'Étang-la-Ville
About your organization / profile
Cabestelle Biopharma develops antibodies for auto-immune, inflammatory diseqses including fibrotic diseases, in particular bispecific antibodies. Cabestelle targets rare orphan diseases such as Sjoegren-Gougerot, Systemic Sclerosis or SLE (Systemic Lupus Erythematosus).
Scientific founders come from the Academic world (Inserm/Univ Paris, CNRS/Univ Bordeaux leader of EIC Pathfinder project).
Network (0)
There are no organizations in the network.
Recent activities
Augustin Godard has joined Cabestelle Biopharma.